ES2074916T3 - Derivados de 2-ciano-3-hidroxi-enamidas, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas que los contienen y los productos intermedios obtenidos. - Google Patents

Derivados de 2-ciano-3-hidroxi-enamidas, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas que los contienen y los productos intermedios obtenidos.

Info

Publication number
ES2074916T3
ES2074916T3 ES93400024T ES93400024T ES2074916T3 ES 2074916 T3 ES2074916 T3 ES 2074916T3 ES 93400024 T ES93400024 T ES 93400024T ES 93400024 T ES93400024 T ES 93400024T ES 2074916 T3 ES2074916 T3 ES 2074916T3
Authority
ES
Spain
Prior art keywords
application
contain
pharmaceutical compositions
enamids
hidroxi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93400024T
Other languages
English (en)
Inventor
Robert R Bartlett
David P Kay
Elizabeth A Kuo
Rudolf Schleyerbach
Wilfried Schwab
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of ES2074916T3 publication Critical patent/ES2074916T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/23—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same unsaturated acyclic carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

LA SOLICITUD SE REFIERE A LOS PRODUCTOS (I) EN LOS QUE: R1 REPRESENTA R13, R14 O R15 REPRESENTAN H, HALOGENO O ALQUILO (C1-3), N = 1. 2 O 3, -6),CO-ALQUILO (C2-6), CICLOALQUILO (C3-6), ALCOXI I ALQUILTIO (C1-6) O -(CH2)M-CF3), -O-(CH2)M-CF3, -S-(CH2)M-CF3 UN RADICAL CF2-HAL, -OCF2-HAL, CON R8, R9, R10, R11 Y R12 TENIENDO VALORES INDICADOS PARA R3, R4, R5, R6 Y R7 O FORMAN -O-CH2-O, SUS FORMAS TAUTOMERAS Y SUS SALE, ASI COMO SU PROCESO DE PREPARACION, SU APLICACION COMO MEDICAMENTOS ANTIINFLAMATORIOS, Y LAS COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
ES93400024T 1992-01-08 1993-01-07 Derivados de 2-ciano-3-hidroxi-enamidas, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas que los contienen y los productos intermedios obtenidos. Expired - Lifetime ES2074916T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929200275A GB9200275D0 (en) 1992-01-08 1992-01-08 Chemical compounds

Publications (1)

Publication Number Publication Date
ES2074916T3 true ES2074916T3 (es) 1995-09-16

Family

ID=10708234

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93400024T Expired - Lifetime ES2074916T3 (es) 1992-01-08 1993-01-07 Derivados de 2-ciano-3-hidroxi-enamidas, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas que los contienen y los productos intermedios obtenidos.

Country Status (22)

Country Link
US (1) US5308865A (es)
EP (1) EP0551230B1 (es)
JP (1) JP3145824B2 (es)
KR (1) KR100276182B1 (es)
CN (1) CN1034499C (es)
AT (1) ATE125252T1 (es)
AU (1) AU652088B2 (es)
BR (1) BR9300035A (es)
CA (1) CA2086908C (es)
CZ (1) CZ285586B6 (es)
DE (1) DE69300261T2 (es)
DK (1) DK0551230T3 (es)
ES (1) ES2074916T3 (es)
FI (1) FI111361B (es)
GB (1) GB9200275D0 (es)
HU (1) HU215843B (es)
IL (1) IL104225A (es)
NO (1) NO179444C (es)
NZ (1) NZ245631A (es)
RU (1) RU2112772C1 (es)
TW (1) TW234116B (es)
ZA (1) ZA93134B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994024095A1 (en) * 1993-04-16 1994-10-27 Abbott Laboratories Immunosuppressive agents
GB9313365D0 (en) * 1993-06-29 1993-08-11 Roussel Lab Ltd Chemical compounds
GB9322781D0 (en) * 1993-11-04 1993-12-22 Roussel Lab Ltd Aromatic amides
US6335356B1 (en) 1994-01-07 2002-01-01 Sugen, Inc. Method of treating a patient by parenteral administration of a lipophilic compound
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
US5610173A (en) * 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
US5721277A (en) * 1995-04-21 1998-02-24 Sugen, Inc. Compounds and methods for inhibiting hyper-proliferative cell growth
GB9520092D0 (en) * 1995-10-02 1995-12-06 Hoechst Roussel Ltd Chemical compounds
DE19539638A1 (de) * 1995-10-25 1997-04-30 Hoechst Ag Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen
DE19547648A1 (de) 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
US6011051A (en) * 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
DE19702988A1 (de) 1997-01-28 1998-07-30 Hoechst Ag Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika
DE19711800A1 (de) * 1997-03-21 1998-09-24 Hoechst Ag Verlängerung der Expression von transgenen Proteinen durch immunmodulierende Behandlung
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
MXPA00010150A (es) * 1998-04-17 2002-05-14 Parker Hughes Inst Inhibidores de btk y metodos para su identificacion y uso.
US6303652B1 (en) * 1998-08-21 2001-10-16 Hughes Institute BTK inhibitors and methods for their identification and use
KR20040101381A (ko) * 2002-04-16 2004-12-02 후지사와 야꾸힝 고교 가부시키가이샤 신규한 용도
EP1609778A1 (en) * 2003-03-24 2005-12-28 Astellas Pharma Inc. Process for production of 2-cyano-3-hydroxy-n-(4-tri- fluoromethylphenyl)hept-2-en-6-ynamide and process for production of polymorphs thereof
CA2558596A1 (en) * 2004-03-05 2005-09-15 Astellas Pharma Inc. Anti fk778 antibodies and high sensitive immunoassay methods
DE102005017592A1 (de) * 2005-04-16 2006-10-19 Lindner, Jürgen, Dr. med. Darreichungsformen und Kombinationspräparate von Pyrimidinbiosyntheseinhibitoren zur Erzielung zusätzlicher Wirkungen auf das Immunsystem
WO2009064938A1 (en) * 2007-11-16 2009-05-22 Abbott Laboratories Method of treating arthritis
PL2632451T3 (pl) 2010-10-29 2018-04-30 Algiax Pharmaceuticals Gmbh Zastosowanie malononitryloamidów w bólu neuropatycznym
AU2014352920A1 (en) 2013-11-22 2016-06-23 Genzyme Corporation Novel methods for treating neurodegenerative diseases
CN112979509B (zh) * 2021-03-10 2022-04-22 江西师范大学 一种三氟甲磺酰基炔酰胺类化合物及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR484223A (fr) * 1916-03-21 1917-09-14 Zenith Carburateur Soc Du Perfectionnements aux carburateurs de moteurs à explosions
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2555789A1 (de) * 1975-12-11 1977-07-07 Hoechst Ag Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
US4346097A (en) * 1980-09-30 1982-08-24 Warner-Lambert Company Method for treating convulsions with pyrazole-4-carboxamide derivatives
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
BR9008022A (pt) * 1990-05-18 1993-04-06 Hoechst Ag Amida de acido isoxazol-4-carboxilico e amidas de acido hidroxialquilideno-cianoacetico,medicamentos contendo estes compostos e sua aplicacao
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them

Also Published As

Publication number Publication date
JP3145824B2 (ja) 2001-03-12
FI111361B (fi) 2003-07-15
RU2112772C1 (ru) 1998-06-10
HUT63377A (en) 1993-08-30
DE69300261T2 (de) 1995-12-07
KR100276182B1 (ko) 2000-12-15
FI930048A (fi) 1993-07-09
DE69300261D1 (de) 1995-08-24
NZ245631A (en) 1994-12-22
US5308865A (en) 1994-05-03
GB9200275D0 (en) 1992-02-26
JPH05310672A (ja) 1993-11-22
NO179444B (no) 1996-07-01
NO930036D0 (no) 1993-01-07
AU3103593A (en) 1993-07-15
ZA93134B (en) 1994-01-10
NO930036L (no) 1993-07-09
CA2086908A1 (en) 1993-07-09
ATE125252T1 (de) 1995-08-15
HU9300022D0 (en) 1993-04-28
AU652088B2 (en) 1994-08-11
CN1079216A (zh) 1993-12-08
CN1034499C (zh) 1997-04-09
CA2086908C (en) 2005-06-14
CZ285586B6 (cs) 1999-09-15
EP0551230A1 (fr) 1993-07-14
BR9300035A (pt) 1993-07-13
NO179444C (no) 1996-10-09
IL104225A0 (en) 1993-05-13
IL104225A (en) 1998-01-04
DK0551230T3 (da) 1997-03-10
FI930048A0 (fi) 1993-01-07
EP0551230B1 (fr) 1995-07-19
KR930016395A (ko) 1993-08-26
CZ382692A3 (en) 1994-03-16
HU215843B (hu) 1999-09-28
TW234116B (en) 1994-11-11

Similar Documents

Publication Publication Date Title
ES2074916T3 (es) Derivados de 2-ciano-3-hidroxi-enamidas, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas que los contienen y los productos intermedios obtenidos.
ES2071510T3 (es) Derivados de pirrolidina y de tiazolidina, su preparacion y los medicamentos que les contienen.
ES2080815T3 (es) Derivados de la 1-naftil-piperacina, sus procedimientos de preparacion y composiciones farmaceuticas que los contienen.
MX9300745A (es) Nuevos azaindoles, procedimiento para su preparacion y productos medicinales que los contienen.
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ES2077199T3 (es) Nuevas piperacinas 1,4-disustituidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
NO180474C (no) Fremgangsmåte for potensiering av den analgetiske effekt av curcuminoider
ES2118203T3 (es) Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2099551T3 (es) Nuevos 19-nor-esteroides que tienen en posicion 11 beta una cadena de fenoxialquilsulfonamida o fenoxialquilsulfonilurea, procedimiento y productos intermedios de preparacion, aplicacion como medicamentos y composicion farmaceutica que los contiene.
ATE39248T1 (de) 3-phenyltetrahydropyridin-derivate, herstellungsverfahren und verwendung in therapien.
ATE122562T1 (de) Derivate von penciclovir zur behandlung von hepatitis-b-infektionen.
ES2074144T3 (es) Derivados de 4-fenilmetil-1h-indol, procedimiento y compuestos intermedios de preparacion, aplicacion como medicamentos y composiciones que los contienen.
ES2088567T3 (es) Empleo de derivados de la 2-iminotioazolidin-4-ona como nuevos productos activos para medicamentos.
ES2064670T3 (es) Nuevos derivados de los bisaril-olefinas, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
ES2055123T3 (es) Nuevos derivados de la fenotiazina, su preparacion y las composiciones que les contienen.
ES2091670T3 (es) Nuevos derivados (ciclohexil)-alquenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 551230

Country of ref document: ES